EDITORIAL / PDF
Without Accessible Primary Care, We Are “Dangerously Unprepared” for the Next Pandemic
CUBA’S WOMEN OF SCIENCE – INTERVIEW
Vaccines and Public Trust: Containing COVID-19 in Cuba
Verena Muzio-González PhD DSc
Director of Clinical Research, Genetic Engineering and Biotechnology Center
Conner Gorry MA / PDF
INTERVIEW
Cuban Covid-19 Vaccines for Children:
Rinaldo Puga MD MS
Principal Investigator, Pediatric Clinical Trials for Soberana 02 and Soberana Plus
Gail Reed MS / PDF
In Haiti, Cubans Among First Responders, Again:
Luis Orlando Oliveros-Serrano MD
Coordinator, Cuban Medical Team in Haiti
Conner Gorry MA / PDF
ORIGINAL RESEARCH
Asymptomatic SARS-CoV-2 Infection in Havana, Cuba, March–June 2020:
Epidemiological Implications
Elba Cruz-Rodríguez MD MS, et al. / PDF
Cerebral Hemodynamic Reserve Abnormalities Detected Via
Transcranial Doppler Ultrasound in Recovered COVID-19 Patients
Anselmo A. Abdo-Cuza MD MS PhD, et al. / PDF
COVID-19 CASE STUDY
Thrombotic Microangiopathy in Patients Recovering from COVID-19
Laura López-Marín MD MS, et al. / PDF
SHORT ARTICLE
Effects of Physical Exercise on Burnout Syndrome in University Students
Yury Rosales-Ricardo MS PhD and José P. Ferreira PhD / PDF
Percutaneous Coronary Intervention Versus Myocardial Revascularization
Surgery in Multivessel Coronary Artery Disease: Four-Year Followup
Adrián Naranjo-Domínguez MD MS, et al. / PDF
REVIEW ARTICLE
Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients
Nadia Rodríguez-Rodríguez, et al. / PDF
Carbapenamase-Producing Acinetobacter baumannii in China, Latin America and the Caribbean:
A Systematic Review and Meta-Analysis
Haiyang Yu MD MPH, et al. PDF
PERSPECTIVE
Innate Immune Stimulation Should not be Overlooked in Post-exposure
Prophylaxis and Early Therapy for Coronavirus Infections
Julio C. Aguilar-Rubido PhD, et al. / PDF
VIEWPOINT
Caution Ahead: Traffic Accidents in Cuba
Conner Gorry MA / PDF
ABSTRACTS
Cuban Research in Current International Journals
Special Abstracts Section COVID-19
Cover photo: A Cuban youngster post-vaccination with Soberana 02, one of three Cuban vaccines that have received emergency use authorization for pediatric ages, 2 to 18 years of age.
Photo Courtesy of the Finlay Vaccine Institute, Havana.
